BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 24816774)

  • 1. Treatment related impairments in arm and shoulder in patients with breast cancer: a systematic review.
    Hidding JT; Beurskens CH; van der Wees PJ; van Laarhoven HW; Nijhuis-van der Sanden MW
    PLoS One; 2014; 9(5):e96748. PubMed ID: 24816774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shoulder and arm morbidity in sentinel node-negative breast cancer patients: a systematic review.
    Verbelen H; Gebruers N; Eeckhout FM; Verlinden K; Tjalma W
    Breast Cancer Res Treat; 2014 Feb; 144(1):21-31. PubMed ID: 24496928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of functional shoulder recovery at 1 and 12 months after breast cancer surgery.
    Levy EW; Pfalzer LA; Danoff J; Springer BA; McGarvey C; Shieh CY; Morehead-Gee A; Gerber LH; Stout NL
    Breast Cancer Res Treat; 2012 Jul; 134(1):315-24. PubMed ID: 22527107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longitudinal study of shoulder and arm morbidity in breast cancer survivors 7 years after sentinel lymph node biopsy or axillary lymph node dissection.
    Kootstra JJ; Dijkstra PU; Rietman H; de Vries J; Baas P; Geertzen JH; Hoekstra HJ; Hoekstra-Weebers JE
    Breast Cancer Res Treat; 2013 May; 139(1):125-34. PubMed ID: 23588950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arm and shoulder morbidity following surgery and radiotherapy for breast cancer.
    Johansen S; Fosså K; Nesvold IL; Malinen E; Fosså SD
    Acta Oncol; 2014 Apr; 53(4):521-9. PubMed ID: 24495044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arm lymphoedema and upper limb impairments in sentinel node-negative breast cancer patients: A one year follow-up study.
    De Groef A; Van Kampen M; Tieto E; Schönweger P; Christiaens MR; Neven P; Geraerts I; Gebruers N; Devoogdt N
    Breast; 2016 Oct; 29():102-8. PubMed ID: 27479040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up on shoulder and arm morbidity in patients treated for early breast cancer.
    Hauerslev KR; Madsen AH; Overgaard J; Damsgaard TE; Christiansen P
    Acta Oncol; 2020 Jul; 59(7):851-858. PubMed ID: 32285717
    [No Abstract]   [Full Text] [Related]  

  • 8. Upper limb physical function and adverse effects after breast cancer surgery: a prospective 2.5-year follow-up study and preoperative measures.
    Sagen A; Kaaresen R; Sandvik L; Thune I; Risberg MA
    Arch Phys Med Rehabil; 2014 May; 95(5):875-81. PubMed ID: 24389401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of postoperative physical therapy for upper-limb impairments after breast cancer treatment: a systematic review.
    De Groef A; Van Kampen M; Dieltjens E; Christiaens MR; Neven P; Geraerts I; Devoogdt N
    Arch Phys Med Rehabil; 2015 Jun; 96(6):1140-53. PubMed ID: 25595999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy.
    Nesvold IL; Dahl AA; Løkkevik E; Marit Mengshoel A; Fosså SD
    Acta Oncol; 2008; 47(5):835-42. PubMed ID: 18568481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Swelling, numbness, pain, and their relationship to arm function among breast cancer survivors: a disablement process model perspective.
    Bosompra K; Ashikaga T; O'Brien PJ; Nelson L; Skelly J
    Breast J; 2002; 8(6):338-48. PubMed ID: 12390356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term morbidity after a negative sentinel node in breast cancer patients.
    Verbelen H; Tjalma W; Meirte J; Gebruers N
    Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13077. PubMed ID: 31050088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection--data from a prospective randomised trial.
    Helms G; Kühn T; Moser L; Remmel E; Kreienberg R
    Eur J Surg Oncol; 2009 Jul; 35(7):696-701. PubMed ID: 18838245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer.
    Rietman JS; Dijkstra PU; Geertzen JH; Baas P; de Vries J; Dolsma WV; Groothoff JW; Eisma WH; Hoekstra HJ
    Ann Surg Oncol; 2004 Nov; 11(11):1018-24. PubMed ID: 15525832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A patient- and assessor-blinded randomized controlled trial of axillary reverse mapping (ARM) in patients with early breast cancer.
    Beek MA; Gobardhan PD; Klompenhouwer EG; Menke-Pluijmers MB; Steenvoorde P; Merkus JW; Rutten HJ; Voogd AC; Luiten EJ
    Eur J Surg Oncol; 2020 Jan; 46(1):59-64. PubMed ID: 31402072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of exercise programmes on shoulder mobility and lymphoedema after axillary lymph node dissection for breast cancer: systematic review.
    Chan DN; Lui LY; So WK
    J Adv Nurs; 2010 Sep; 66(9):1902-14. PubMed ID: 20626480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The perioperative educational program for improving upper arm dysfunction in patients with breast cancer: a controlled trial.
    Sato F; Ishida T; Ohuchi N
    Tohoku J Exp Med; 2014 Feb; 232(2):115-22. PubMed ID: 24561542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Influence of Arm Swelling Duration on Shoulder Pathology in Breast Cancer Patients with Lymphedema.
    Jang DH; Kim MW; Oh SJ; Kim JM
    PLoS One; 2015; 10(11):e0142950. PubMed ID: 26571274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-reported arm and shoulder problems in breast cancer survivors in Sub-Saharan Africa: the African Breast Cancer-Disparities in Outcomes cohort study.
    Boucheron P; Anele A; Zietsman A; Galukande M; Parham G; Pinder LF; Andersson TM; Anderson BO; Foerster M; Schüz J; Dos Santos Silva I; McCormack V
    Breast Cancer Res; 2021 Nov; 23(1):109. PubMed ID: 34819118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer.
    Rietman JS; Geertzen JH; Hoekstra HJ; Baas P; Dolsma WV; de Vries J; Groothoff JW; Eisma WH; Dijkstra PU
    Eur J Surg Oncol; 2006 Mar; 32(2):148-52. PubMed ID: 16387467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.